.webp)
Venom from the geography cone snail reveals promising new approach to treating diabetes and hormone disorders.
Scientists at the University of Utah Health have revealed a potential breakthrough in drug development from an unexpected source: the venom of the geography cone snail, one of the world’s most venomous creatures. Their study, published in Nature Communications on August 20, 2024, highlights a toxin called consomatin, which mimics the human hormone somatostatin, known for regulating blood sugar and hormone levels.
Consomatin’s unique properties make it an intriguing candidate for new medications. Unlike somatostatin, which interacts with multiple proteins, consomatin targets just one, offering a more precise approach to drug design. This specificity could lead to medications with fewer side effects compared to current synthetic drugs.
The toxin’s stability and longevity in the body—thanks to a rare amino acid—further enhance its potential. Researchers suggest that by studying consomatin’s structure and function, pharmaceutical scientists could develop improved treatments for endocrine disorders and diabetes with prolonged efficacy and reduced adverse effects.
Helena Safavi, PhD, senior author of the study, notes that the cone snail’s evolutionarily honed venom, including consomatin and an insulin-like toxin, demonstrates nature’s ability to craft highly effective biochemical tools. This discovery underscores the potential for venom-derived compounds to inspire advanced therapeutic strategies.
.webp)
